Professional Biographies

Steve Vanderboom

Steve Vanderboom is the President and Chief Executive Officer of Pace Analytical Life Sciences. Steve has more than 25 years of experience in the analytical services industry, specifically in the areas of analytical testing, field services and environmental consulting. Mr. Vanderboom co-founded Pace Laboratories, Inc. in 1978 and subsequently took the position of President and CEO of Pace Analytical Services, Inc. when it was formed in 1995. Pace Analytical is a national company offering analytical services and measurements and employs more than 800 people. Mr. Vanderboom received a M.S. degree in Environmental Engineering and a B.S. degree in Civil Engineering.

Gregory D. Kupp

Greg Kupp is the Vice President and Chief Operating Officer of Pace Analytical Life Sciences. His current responsibilities include the management and oversight of operations, quality systems, research and development, and the administrative functions of PLS. He has over fifteen years experience in analytical chemistry outsourcing and holds a M.S. degree in Quality Assurance/Regulatory Affairs from Temple University.

Previously, he was the Director of Pharmaceutical Chemistry and Client Services for Lancaster Laboratories. His responsibilities included oversight of the release, stability, dissolution and raw material testing areas, as well as the client services and project management group. He was also responsible for overseeing the activities associated with the operation and validation of the Atlas Chromatographic software system and acted as the Pharmaceutical Chemistry lead during client and agency audits. During his tenure at Lancaster Laboratories, he served as group leader within the stability, product release and dissolution testing areas.

Robert M. Reagan

Bob Reagan is the Vice President of Sales and Marketing for Pace Analytical Life Sciences. His current responsibilities include managing and coordinating all of Pace Analytical Life Sciences sales, marketing and business development activities. Bob has more than 25 years experience working in the pharmaceutical industry. He has more than 15 fifteen years experience supporting pharmaceutical, biopharmaceutical and medical device outsourcing, including more than 10 years managing and directing analytical chemistry and analytical development and validation groups.

Previously, Bob worked at Lancaster Laboratories for 15 years. Most recently he held the position of Senior Director of Business Development and Client Services. His responsibilities included oversight of a team consisting of 45 sales and marketing professionals. He was responsible for developing the revenue stream for Lancaster Labs’ pharmaceutical and biopharmaceutical laboratories. Prior to joining Lancaster Labs, Bob was employed as the Manager of Analytical Research and Development at Hercon Laboratories – and prior to that – Bob was a research chemist at Ciba-Geigy (now Novartis).

Cynthia Hansen

Cynthia Hansen is the Director of Quality for Pace Analytical Life Sciences. Her current responsibilities include directing the activities of the Quality Assurance, IT and Facilities staff. She has more than 15 years experience in analytical chemistry laboratories, including 10 years in the FDA regulated industry. Cynthia holds a M.S. degree in Environmental Engineering and a B.S. Degree in Chemistry.

Previously, she was the Director of Quality and Regulatory for P3 Scientific. Her responsibilities included oversight of the quality systems, maintaining excellent regulatory compliance and facilitating accreditation to ISO/IEC 17025:2005. During her tenure at P3 Scientific, she served as Chemist and Group Leader prior to moving into Quality Assurance.

Mark Schwab

Mark Schwab is the Director of Method Development and Validation and Medical Device Chemistry for Pace Analytical Life Sciences. Mark has been with Pace Analytical Services for more than 10 years and brings extensive experience in developing and validating analytical methods used in characterizing materials in the Medical Device and Pharmaceutical industries He is responsible for overseeing the activities associated with the development of new analytical technologies as well as the development of testing services to meet the requirements of ISO 10993. He is an active member of the Association for the Advancement of Medical Instrumentation (AAMI) and is a voting member in AAMI/BE/WG 14 “Material Characterization” and AAMI/BE/WG 63 “Sterilization Residuals WG.”